Gonadal Function and Immunosuppressive Therapy After Renal Transplantation

End-stage renal disease is associated with disorders in hypothalamic-pituitary-gonadal function. Immunosuppressive therapies may influence the restoration of normal levels of gonadal hormones after renal transplantation. The aim of the present study was to evaluate the hormonal status of successful...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 2005-05, Vol.37 (4), p.1915-1917
Main Authors: Tondolo, V., Citterio, F., Panocchia, N., Nanni, G., Favi, E., Brescia, A., Castagneto, M.
Format: Article
Language:English
Subjects:
Biological and medical sciences
Creatinine - blood
Follicle Stimulating Hormone - blood
Follow-Up Studies
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Humans
Immunosuppressive Agents - adverse effects
Kidney Transplantation - immunology
Kidney Transplantation - physiology
Luteinizing Hormone - blood
Male
Medical sciences
Middle Aged
Regression Analysis
Sirolimus - adverse effects
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Testosterone - blood
Time Factors
Tissue, organ and graft immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:End-stage renal disease is associated with disorders in hypothalamic-pituitary-gonadal function. Immunosuppressive therapies may influence the restoration of normal levels of gonadal hormones after renal transplantation. The aim of the present study was to evaluate the hormonal status of successful renal transplant recipients who were treated with different immunosuppressive agents. Testosterone, luteinizing hormone (LH), and follicle stimulating hormone (FSH) were measured in 59 male renal transplant recipients with stable graft function with serum creatinine
ISSN:0041-1345
1873-2623
DOI:10.1016/j.transproceed.2005.04.004